The Aperlena Verdict
Open raceNo supplier dominates: 132 different companies have won the last 297 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- -55.5%
- Expected final price vs the published estimate
Based on 297 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis Czech public tender covers recurring supplies of medicinal products whose active substance is lenvatinib. The products must meet the requirements of SÚKL, the Czech State Institute for Drug Control. The procurement concerns repeated deliveries of these antineoplastic and immunomodulating medicines. The notice does not specify the contracting authority by name, the estimated contract value, the submission deadline, or the award procedure, so interested suppliers should consult the full tender documents for those details. Suppliers of medicinal products able to meet SÚKL requirements are the intended audience. All factual details beyond those stated here are available in the official tender documentation published by the buyer.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 6 days ago
More from this buyer
Full buyer profile44 open tenders right now
- Medical needles - Echogenic needle 1 day left
- Vascular prostheses - Linear ePTFE vascular prosthesis 1 day left
- Czech Republic - Antineoplastic and immunomodulating agents - INTERFERON BETA-1A 2026 2 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Alliance Healthcare s.r.o. | 28 | €17.6M | Aug 2026 |
| PHOENIX lékárenský velkoobchod, s.r.o. | 26 | €17.9M | Aug 2026 |
| PHARMOS, a.s. | 12 | €4.9M | Jun 2026 |
| PROMEDICA PRAHA GROUP, a.s. | 11 | €3.9M | Aug 2026 |
| Boston Scientific Česká republika s.r.o. | 10 | €3.5M | Aug 2026 |
Based on 297 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 300 comparable contracts this buyer awarded in this sector over the last 4 years.
- €83,225
- Lower quartile
- €181,723
- Median award
- €585,895
- Upper quartile
This tender is estimated 375% above that median
Most recent awards
- Česko - Antineoplastika - LP s obsahem izatuximabu 2026 €1,953,942
- Česko - Chirurgické implantáty - Implantát k léčbě prolapsu pánevního dna €60,694
- Česko - Katétry - Katétr CVC 5 lumen antibakteriální vč. setu rouškovacího €50,852
- Česko - Anestetika - LP s obsahem fentanylu 2026 II. €454,249
- Česko - Oftalmologika - Fluoruracil I.V. 2026 €135,148
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€548,450
est. value
1
day left
€1,436,973
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,804,288
- Buyer track record on Aperlena
- 761 notices tracked · 400 awarded
- €531,888,821 in awarded contracts
Never miss a tender like this
149 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert